drugset / Trial / NCT02937896

Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control

NCT02937896

RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is the comparison of efficacy of intravenous ketorolac and intranasal desmopressin in renal colic patients pain control.

Timeline

Start
2015-01
Primary completion
2016-02
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desmopressin Peptide 40 ug Intranasal
Subject Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.